How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus

We recommend strongly that methodological transparency is awarded a much more important role in the conduct of NA analyses made on the basis of pharmacy claims data. </AbstractSection> Copyright Springer-Verlag 2013

MoreLess

Year of publication:	2013
Authors:	Wilke, Thomas ; Groth, Antje ; Mueller, Sabrina ; Reese, Dallas ; Linder, Roland ; Ahrens, Susanne ; Verheyen, Frank
Published in:	The European Journal of Health Economics. - Springer. - Vol. 14.2013, 3, p. 551-568
Publisher:	Springer
Subject:	Non-adherence \| Non-compliance \| Claims-data \| Pharmacy claims data \| Adherence \| Measurement \| Type 2 diabetes

More details

Extent:	text/html
Type of publication:	Article
Source:	RePEc - Research Papers in Economics

Persistent link: https://www.econbiz.de/10010993835